Gout and Cardiovascular Risk

References1. White WB, Saag KG, Becker MA, et al; CARES Investigators. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018;378:1200-1210.2. Keller SF, Rai SK, Lu N, et al. Statin use and mortality in gout: a general population-based cohort study. Semin Arthritis Rheum. Published online: March 17, 2018. doi.org/10.1016/j.semarthrit.2018.03.007